|
🐜
|
Safety of probiotics that contain lactobacilli or bifidobacteria.
7 auth.
S. Borriello,
W. Hammes,
W. Holzapfel,
P. Marteau,
J. Schrezenmeir,
M. Vaara,
...
V. Valtonen
|
9 |
2003 |
9
🐜
|
|
🐜
|
Value of body fat mass vs anthropometric obesity indices in the assessment of metabolic risk factors
7 auth.
A. Bosy-Westphal,
C. Geisler,
S. Onur,
O. Korth,
O. Selberg,
J. Schrezenmeir,
...
M. Müller
|
8 |
2006 |
8
🐜
|
|
🐬
|
Guidance for substantiating the evidence for beneficial effects of probiotics: prevention and management of infections by probiotics.
D. Wolvers,
J. Antoine,
E. Myllyluoma,
J. Schrezenmeir,
H. Szajewska,
G. Rijkers
|
8 |
2010 |
8
🐬
|
|
🐢
|
Consumption of a fermented dairy product containing the probiotic Lactobacillus casei DN-114 001 reduces the duration of respiratory infections in the elderly in a randomised controlled trial
E. Guillemard,
F. Tondu,
F. Lacoin,
J. Schrezenmeir
|
7 |
2009 |
7
🐢
|
|
🐢
|
Probiotic bacteria stimulate
virus–specific neutralizing antibodies
following a booster polio vaccination
M. de Vrese,
P. Rautenberg,
C. Laue,
M. Koopmans,
T. Herremans,
J. Schrezenmeir
|
7 |
2005 |
7
🐢
|
|
🐜
|
Ciclosporin and prednisone v. prednisone in treatment of Graves' ophthalmopathy: a controlled, randomized and prospective study
8 auth.
G. Kahaly,
J. Schrezenmeir,
U. Krause,
B. Schweikert,
S. Meuer,
W. Muller,
...
R. Dennebaum,
J. Beyer
|
7 |
1986 |
7
🐜
|
|
🐢
|
Effects of probiotic bacteria and their genomic DNA on TH1/TH2-cytokine production by peripheral blood mononuclear cells (PBMCs) of healthy and allergic subjects.
D. Ghadimi,
R. Fölster-Holst,
M. de Vrese,
P. Winkler,
K. Heller,
J. Schrezenmeir
|
7 |
2008 |
7
🐢
|
|
🐜
|
Prospective, randomized controlled trial on Lactobacillus rhamnosus in infants with moderate to severe atopic dermatitis
10 auth.
R. Fölster-Holst,
F. Müller,
N. Schnopp,
D. Abeck,
I. Kreiselmaier,
T. Lenz,
...
U. V. Rüden,
J. Schrezenmeir,
E. Christophers,
M. Weichenthal
|
7 |
2006 |
7
🐜
|
|
🐢
|
Effect of quercetin on traits of the metabolic syndrome, endothelial function and inflammation in men with different APOE isoforms.
11 auth.
M. Pfeuffer,
A. Auinger,
U. Bley,
I. Kraus-Stojanowic,
C. Laue,
P. Winkler,
...
C. Rüfer,
J. Frank,
C. Bösch-Saadatmandi,
G. Rimbach,
J. Schrezenmeir
|
7 |
2013 |
7
🐢
|
|
🐜
|
A Genome-Wide Association Study Identifies LIPA as a Susceptibility Gene for Coronary Artery Disease
90 auth.
P. Wild,
T. Zeller,
A. Schillert,
S. Szymczak,
C. Sinning,
A. Deiseroth,
Cand Med,
R. Schnabel,
E. Lubos,
T. Keller,
M. Eleftheriadis,
C. Bickel,
H. Rupprecht,
Sandra Wilde,
H. Rossmann,
...
P. Diemert,
L. Cupples,
C. Perret,
J. Erdmann,
K. Stark,
M. Kleber,
S. Epstein,
B. Voight,
K. Kuulasmaa,
Mingyao Li,
Arne S Schäfer,
N. Klopp,
P. Braund,
H. Sager,
S. Demissie,
Carole Proust,
I. König,
H. Wichmann,
Wibke Reinhard,
M. Hoffmann,
J. Virtamo,
M. Burnett,
D. Siscovick,
P. Wiklund,
L. Qu,
Nour Eddine El Mokthari,
J. Thompson,
A. Peters,
A. Smith,
E. Yon,
J. Baumert,
C. Hengstenberg,
W. März,
P. Amouyel,
J. Devaney,
S. Schwartz,
O. Saarela,
N. Mehta,
Diana Rubin,
K. Silander,
A. Hall,
J. Ferrières,
T. Harris,
O. Melander,
F. Kee,
H. Hakonarson,
J. Schrezenmeir,
V. Gudnason,
R. Elosúa,
D. Arveiler,
A. Evans,
D. Rader,
T. Illig,
S. Schreiber,
J. Bis,
D. Altshuler,
M. Kavousi,
J. Witteman,
A. Uitterlinden,
A. Hofman,
A. Folsom,
M. Barbalić,
E. Boerwinkle,
S. Kathiresan,
M. Reilly,
C. O’Donnell,
N. Samani,
H. Schunkert,
F. Cambien,
K. Lackner,
L. Tiret,
V. Salomaa,
T. Munzel,
A. Ziegler,
S. Blankenberg
|
7 |
2011 |
7
🐜
|
|
🐢
|
Effect of a dietary supplement containing probiotic bacteria plus vitamins and minerals on common cold infections and cellular immune parameters.
P. Winkler,
M. Vrese,
C. Laue,
J. Schrezenmeir
|
6 |
2005 |
6
🐢
|
